Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Lambert, John S; Moye Jr, Jack; Plaeger, Susan F et al. (2005) Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection. Clin Diagn Lab Immunol 12:622-31
Watts, D Heather; Lambert, John; Stiehm, E Richard et al. (2003) Progression of HIV disease among women following delivery. J Acquir Immune Defic Syndr 33:585-93
Lambert, John S; Harris, D Robert; Stiehm, E Richard et al. (2003) Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection. J Acquir Immune Defic Syndr 34:512-9
Lambert, J S; Watts, D H; Mofenson, L et al. (2000) Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 Team. AIDS 14:1389-99
Henderson, R A; Talusan, K; Hutton, N et al. (1999) Whole body protein turnover in children with human immunodeficiency virus (HIV) infection. Nutrition 15:189-94
Stiehm, E R; Lambert, J S; Mofenson, L M et al. (1999) Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185. J Infect Dis 179:567-75
Henderson, R A; Talusan, K; Hutton, N et al. (1998) Resting energy expenditure and body composition in children with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 19:150-7
Lambert, J S; Viscidi, R; Walker, M C et al. (1997) Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine. The National Institute of Allergy and Infectious Clin Diagn Lab Immunol 4:302-8
Lambert, J S; Mofenson, L M; Fletcher, C V et al. (1997) Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group. J Infect Dis 175:283-91
Henderson, R A; Talusan, K; Hutton, N et al. (1997) Serum and plasma markers of nutritional status in children infected with the human immunodeficiency virus. J Am Diet Assoc 97:1377-81

Showing the most recent 10 out of 20 publications